Effectiveness and Safety of Dapagliflozin for Black vs White Patients With Chronic Kidney Disease in North and South America: A Secondary Analysis of a Randomized Clinical Trial

被引：6
|
作者：
Vart, Priya [1 ]
Jongs, Niels [1 ]
Wheeler, David C. [2 ]
Heerspink, Hiddo J. L. [1 ,3 ]
Langkilde, Anna Maria [4 ]
Chertow, Glenn M. [5 ,6 ]
机构：
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands
[2] UCL, Dept Renal Med, London, England
[3] George Inst Global Hlth, Sydney, NSW, Australia
[4] AstraZeneca, BioPharmaceut R&D, Gotherburg, Sweden
[5] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA
[6] Stanford Univ, Sch Med, Dept Epidemiol & Populat Hlth, Stanford, CA 94305 USA
来源：
JAMA NETWORK OPEN | 2023年 / 6卷 / 04期
关键词：
RACIAL-DIFFERENCES; RISK;
D O I：
10.1001/jamanetworkopen.2023.10877
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Safety and effectiveness of lanthanum carbonate for hyperphosphatemia in chronic kidney disease (CKD) patients: a meta-analysis
    Zhao, Lijuan
    Liu, An
    Xu, Guoshuang
    RENAL FAILURE, 2021, 43 (01) : 1378 - 1393
  • [42] Demographic and clinical profile of black patients with chronic kidney disease attending a tertiary hospital in Johannesburg, South Africa
    Meremo, Alfred
    Paget, Graham
    Duarte, Raquel
    Dickens, Caroline
    Dix-Peek, Therese
    Bintabara, Deogratius
    Naicker, Saraladevi
    PLOS ONE, 2022, 17 (09):
  • [43] Effectiveness of Urate-Lowering Therapy for Renal Function in Patients With Chronic Kidney Disease: A Meta-Analysis of Randomized Clinical Trials
    Liang, Xiuping
    Liu, Xiang
    Li, Duohui
    Qin, Wei
    Liu, Yi
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [44] Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial
    van Ruiten, Charlotte C.
    Van der Aart-van der Beek, Annemarie B.
    IJzerman, Richard G.
    Nieuwdorp, Max
    Hoogenberg, K.
    van Raalte, Daniel H.
    Heerspink, Hiddo J. L.
    DIABETES OBESITY & METABOLISM, 2021, 23 (08): : 1851 - 1858
  • [45] Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction A Prespecified Analysis of the DELIVER Randomized Clinical Trial
    Mc Causland, Finnian R.
    Claggett, Brian L.
    Vaduganathan, Muthiah
    Desai, Akshay S.
    Jhund, Pardeep
    de Boer, Rudolf A.
    Docherty, Kieran
    Fang, James
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Martinez, Felipe
    Saraiva, Jose F. Kerr
    McGrath, Martina M.
    Shah, Sanjiv J.
    Verma, Subodh
    Langkilde, Anna Maria
    Petersson, Magnus
    McMurray, John J., V
    Solomon, Scott D.
    JAMA CARDIOLOGY, 2023, 8 (01) : 56 - 65
  • [46] Plating vs Closed Reduction for Fractures in the Distal Radius in Older Patients A Secondary Analysis of a Randomized Clinical Trial
    Lawson, Andrew
    Naylor, Justine
    Buchbinder, Rachelle
    Ivers, Rebecca
    Balogh, Zsolt J.
    Smith, Paul
    Xuan, Wei
    Howard, Kirsten
    Vafa, Arezoo
    Perriman, Diana
    Mittal, Rajat
    Yates, Piers
    Rieger, Bertram
    Smith, Geoff
    Adie, Sam
    Elkinson, Ilia
    Kim, Woosung
    Sungaran, Jai
    Latendresse, Kim
    Wong, James
    Viswanathan, Sameer
    Landale, Keith
    Drobetz, Herwig
    Phong Tran
    Page, Richard
    Beattie, Sally
    Mulford, Jonathan
    Incoll, Ian
    Kale, Michael
    Schick, Bernard
    Li, Trent
    Higgs, Andrew
    Oppy, Andrew
    Harris, Ian A.
    JAMA SURGERY, 2022, 157 (07) : 563 - 571
  • [47] Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Jhund, Pardeep
    de Boer, Rudolf A.
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Martinez, Felipe
    Shah, Sanjiv J.
    Desai, Akshay S.
    Hegde, Sheila M.
    Lindholm, Daniel
    Petersson, Magnus
    Langkilde, Anna Maria
    McMurray, John J., V
    Solomon, Scott D.
    JAMA CARDIOLOGY, 2022, 7 (12) : 1259 - 1263
  • [48] Safety and Efficacy of Roxadustat for Anemia in Patients With Chronic Kidney Disease: A Meta-Analysis and Trial Sequential Analysis
    Liu, Chao
    Fu, Zhangning
    Jiang, Jiawei
    Chi, Kun
    Geng, Xiaodong
    Mao, Zhi
    Song, Chengcheng
    Sun, Guannan
    Hong, Quan
    Cai, Guangyan
    Chen, Xiangmei
    Sun, Xuefeng
    FRONTIERS IN MEDICINE, 2021, 8
  • [49] Cost-effectiveness analysis of intravenous paricalcitol vs. oral calcitriol in the treatment of hyperparathyroidism secondary to chronic kidney disease
    Cardoso, Marilia Mastrocolla de Almeida
    Machado-Rugolo, Juliana
    Lima, Silvana Andrea Molina
    Andrade, Luis Gustavo Modelli de
    Curado, Daniel da Silva Pereira
    Ponce, Daniela
    JORNAL BRASILEIRO DE NEFROLOGIA, 2023, 45 (01): : 95 - 101
  • [50] Effectiveness of Virtual vs In-Person Inhaler Education for Hospitalized Patients With Obstructive Lung Disease A Randomized Clinical Trial
    Press, Valerie G.
    Arora, Vineet M.
    Kelly, Colleen A.
    Carey, Kyle A.
    White, Steve R.
    Wan, Wen
    JAMA NETWORK OPEN, 2020, 3 (01) : E1918205
12345